Our findings suggest that targeting people with high apoB with EPA and DHA may help reduce their risk of T2D and ...

Millions of Medicaid beneficiaries have limited access to Type 2 diabetes medications that reduce the risk of cardiovascular disease, according to a study published April 22 in Annals of Internal ...

Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...

MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to ...

Apr. 8, 2025 — New research has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes -- not the presence of certain fats, but their suppression. The study ...

A data-informed approach to scheduling patient encounters with clinicians can reduce risks associated with diabetes management by up to 19.4%, especially for underserved populations, says new research ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

Novo Nordisk’s SOUL trial confirms that oral semaglutide significantly reduces the risk of heart attack, stroke, and ...